Non-valvular atrial fibrillation (NVAF).
作者信息
Roderick E, Cox J
出版信息
Br J Gen Pract. 1997 Oct;47(423):660-1.
Abstract
摘要
相似文献
1
Non-valvular atrial fibrillation (NVAF).
Br J Gen Pract. 1997 Oct;47(423):660-1.
2
Anticoagulation in patients with non-valvular atrial fibrillation: an evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK population.
Curr Med Res Opin. 2005 Dec;21(12):1905-13. doi: 10.1185/030079905X75050.
3
[Ximelagatran cannot be an alternative to standard warfarin therapy in chronic atrial fibrillation/ antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
Anadolu Kardiyol Derg. 2007 Jun;7(2):217-8; author reply 218-9.
4
Anti-thrombotic therapy prescribed for patients with non-rheumatic atrial fibrillation (Scot Med J 1994: 39; 110-111).
Scott Med J. 1994 Oct;39(5):139-40.
5
Which patients with atrial fibrillation do not need anticoagulation therapy with warfarin?
Am Fam Physician. 2004 Sep 1;70(5):917-8.
6
Atrial fibrillation and anticoagulation.
Med Health R I. 2001 Dec;84(12):410-1.
7
Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
Thromb Haemost. 2008 Jul;100(1):14-5. doi: 10.1160/TH08-06-0344.
8
Anti-thrombotic therapy prescribed for patients with non-rheumatic atrial fibrillation (Scot Med J 1994:39;110-111).
Scott Med J. 1994 Oct;39(5):140.
9
Patterns of anticoagulation in patients hospitalized with atrial fibrillation: warfarin is underused in paroxysmal atrial fibrillation.
Conn Med. 2003 Nov-Dec;67(10):595-8.
10
Choosing between warfarin (Coumadin) and aspirin therapy for patients with atrial fibrillation.
Am Fam Physician. 2005 Jun 15;71(12):2348-50.
引用本文的文献
1
Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation.
BMJ. 1999 May 15;318(7194):1324-7. doi: 10.1136/bmj.318.7194.1324.
本文引用的文献
1
Warfarin anticoagulation in primary care: a regional survey of present practice and clinicians' views.
Br J Gen Pract. 1997 May;47(418):309-10.
2
Cost-effectiveness of stroke prophylaxis for nonvalvular atrial fibrillation.
JAMA. 1996 Mar 27;275(12):909; author reply 910. doi: 10.1001/jama.275.12.909.
Zotero 插件